메뉴 건너뛰기




Volumn 33, Issue 7, 2010, Pages 498-503

Reversibility of hepatitis B virus-induced liver cirrhosis after prolonged antiviral therapy;Desaparición de cirrosis hepática por VHB tras tratamiento prolongado con antivirales

Author keywords

Antiviral therapy; Hepatitis B virus; Reversibility of liver cirrhosis

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; IMMUNOGLOBULIN; LAMIVUDINE; VIRUS DNA;

EID: 77956419671     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2010.04.007     Document Type: Article
Times cited : (2)

References (16)
  • 2
    • 42949130108 scopus 로고    scopus 로고
    • Diagnosis and quantification of fibrosis
    • Manning D.S., Afdhal N.H. Diagnosis and quantification of fibrosis. Gastroenterology 2008, 134:1670-1681.
    • (2008) Gastroenterology , vol.134 , pp. 1670-1681
    • Manning, D.S.1    Afdhal, N.H.2
  • 3
    • 13544268721 scopus 로고    scopus 로고
    • Antifibrotic therapy in chronic liver disease
    • Rockey D.C. Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol 2005, 3:95-107.
    • (2005) Clin Gastroenterol Hepatol , vol.3 , pp. 95-107
    • Rockey, D.C.1
  • 4
    • 54549119172 scopus 로고    scopus 로고
    • Current and future anti-fibrotic therapies for chronic liver disease
    • Rockey D.C. Current and future anti-fibrotic therapies for chronic liver disease. Clin Liver Dis 2008, 12:939-962.
    • (2008) Clin Liver Dis , vol.12 , pp. 939-962
    • Rockey, D.C.1
  • 6
    • 33344467649 scopus 로고    scopus 로고
    • Management of chronic hepatitis B virus infection: a new era of disease control
    • Farrell G.C., Teoh N.C. Management of chronic hepatitis B virus infection: a new era of disease control. Intern Med J 2006, 36:100-113.
    • (2006) Intern Med J , vol.36 , pp. 100-113
    • Farrell, G.C.1    Teoh, N.C.2
  • 7
    • 48249112996 scopus 로고    scopus 로고
    • Treatment of hepatitis B virus infection: present and future
    • Planas R., Morillas R.M. Treatment of hepatitis B virus infection: present and future. Gastroenterol Hepatol 2008, 31:349-355.
    • (2008) Gastroenterol Hepatol , vol.31 , pp. 349-355
    • Planas, R.1    Morillas, R.M.2
  • 8
    • 40949140557 scopus 로고    scopus 로고
    • Pharmacological agents for the treatment of chronic hepatitis B
    • Sánchez-Tapias J.M. Pharmacological agents for the treatment of chronic hepatitis B. Gastroenterol Hepatol 2008, 31:120-128.
    • (2008) Gastroenterol Hepatol , vol.31 , pp. 120-128
    • Sánchez-Tapias, J.M.1
  • 9
    • 34147150694 scopus 로고    scopus 로고
    • Reversal of liver cirrosis: a desirable clinical outcome and its pathogenic background
    • Bortolotti F., Guido M. Reversal of liver cirrosis: a desirable clinical outcome and its pathogenic background. J Pediatr Gastroenterol Nutr 2007, 44:401-406.
    • (2007) J Pediatr Gastroenterol Nutr , vol.44 , pp. 401-406
    • Bortolotti, F.1    Guido, M.2
  • 12
    • 0035190894 scopus 로고    scopus 로고
    • Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection
    • Pohl A., Behling C., Oliver D., Kilani M., Monson P., Hassanein T. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 2001, 96:3142-3146.
    • (2001) Am J Gastroenterol , vol.96 , pp. 3142-3146
    • Pohl, A.1    Behling, C.2    Oliver, D.3    Kilani, M.4    Monson, P.5    Hassanein, T.6
  • 13
    • 0036242165 scopus 로고    scopus 로고
    • Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
    • Poynard T., McHutchison J., Manns M., Trepo C., Lindsay K., Goodman Z., et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002, 122:1303-1313.
    • (2002) Gastroenterology , vol.122 , pp. 1303-1313
    • Poynard, T.1    McHutchison, J.2    Manns, M.3    Trepo, C.4    Lindsay, K.5    Goodman, Z.6
  • 14
    • 0041664940 scopus 로고    scopus 로고
    • Reversal of cirrhosis: Evidence-based Medicine?
    • Desmet V.J., Roskams T. Reversal of cirrhosis: Evidence-based Medicine?. Gastroenterology 2003, 125:629-630.
    • (2003) Gastroenterology , vol.125 , pp. 629-630
    • Desmet, V.J.1    Roskams, T.2
  • 15
    • 63049107827 scopus 로고    scopus 로고
    • Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
    • Suzuki Y., Suzuki F., Kawamura Y., Yatsuji H., Sezaki H., Hosaka T., et al. Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?. J Gastroenterol Hepatol 2009, 24:429-435.
    • (2009) J Gastroenterol Hepatol , vol.24 , pp. 429-435
    • Suzuki, Y.1    Suzuki, F.2    Kawamura, Y.3    Yatsuji, H.4    Sezaki, H.5    Hosaka, T.6
  • 16
    • 33645730480 scopus 로고    scopus 로고
    • Peg-interferon improves liver histology in patients with HbeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudina
    • HBV 99-01 Study Group
    • Van Zonneveld M., Zondervan P.E., Cakaloglu Y., Simon C., Akarca U.S., So T.M., et al. Peg-interferon improves liver histology in patients with HbeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudina. Liver Int 2006, 26:399-405. HBV 99-01 Study Group.
    • (2006) Liver Int , vol.26 , pp. 399-405
    • Van Zonneveld, M.1    Zondervan, P.E.2    Cakaloglu, Y.3    Simon, C.4    Akarca, U.S.5    So, T.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.